Mangrove Partners’s BELLUS Health Inc. BLU Stock Holding History

Mangrove Partners’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-948,221	Closed	-$7.63M	–	557
2021 Q4	$7.63M	Buy	+948,221	New	+$6.29M	0.45%	36
2020 Q3	–	Sell	-207,778	Closed	-$2.14M	–	59
2020 Q2	$2.14M	Sell	207,778 -305,906	-60%	-$3.1M	0.52%	35
2020 Q1	$5.13M	Buy	513,684 +77,499	+18%	+$691K	0.71%	28
2019 Q4	$3.31M	Buy	436,185 +122,336	+39%	+$836K	0.49%	31
2019 Q3	$2M	Buy	+313,849	New	+$2.21M	0.24%	65

Other funds holding BLU

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PCOC

Power Corp of Canada Montreal, Quebec, Canada $745M AUM 22.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Mangrove Partners's BLU Position: Q1 2022 in Review

Mangrove Partners sold out of BELLUS Health Inc. (BLU) in Q1 2022, closing a stake of 948,221 shares — an estimated $7.63M sold.

Mangrove Partners first reported a position in BLU in Q3 2019 and held it in 5 quarters. The position peaked at $7.63M in Q4 2021. 77 funds tracked by Wall St. Rank hold BLU as of Q1 2022.

Mangrove Partners reported no remaining BELLUS Health Inc. position as of Q1 2022 after selling out during the quarter.
Mangrove Partners sold 948,221 BELLUS Health Inc. shares in Q1 2022, an estimated $7.63M.
Mangrove Partners first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 5 quarters.
Mangrove Partners's BELLUS Health Inc. position peaked at $7.63M in Q4 2021.
77 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.